Benesh Kathryn 4

What Happened
Kathryn Benesh, a director of CME Group Inc. (CME), was granted 645 shares of Class A common stock on 2026-06-25. The shares were issued at an indicated value of $225.00 per share, totaling $145,125. This was an award (grant) of fully vested stock as part of the company’s director compensation program, not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-06-25
• Grant type/code: A (award/grant) — 645 shares awarded at $225.00 per share; total value $145,125
• Shares subject to vesting: None — footnote states these shares are fully vested and not subject to vesting conditions (CME Group Director Stock Plan)
• Filing date: 2026-06-29 (Form 4 filed with the SEC) — filed on the second business day following the transaction, consistent with Form 4 timing requirements
• Shares owned after transaction: Not specified in the provided filing excerpt

Context
Grants of fully vested shares to non-employee directors are a common component of board compensation and do not imply a purchase or sale signal. For retail investors, such awards are routine and reflect compensation policy rather than an insider expressing a bullish or bearish view by buying or selling stock.